TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
China SXT Pharmaceuticals ( (SXTC) ) has provided an announcement.
On March 13, 2025, China SXT Pharmaceuticals, Inc. entered into a warrant exchange agreement with certain holders of 28,400,000 warrants originally issued in a private investment in public equity. The agreement involved the cancellation of these warrants in exchange for the issuance of 11,225,000 ordinary shares to the holders. This strategic move, approved by the company’s board of directors, was completed on March 18, 2025, and reflects the company’s efforts to optimize its capital structure and potentially enhance shareholder value.
More about China SXT Pharmaceuticals
China SXT Pharmaceuticals, Inc. operates in the pharmaceutical industry, focusing on the development and commercialization of traditional Chinese medicine products. The company is based in Taizhou, Jiangsu, China, and is involved in the production of various medicinal products aimed at addressing health issues through traditional remedies.
YTD Price Performance: -30.94%
Average Trading Volume: 140,549
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $6.4M
See more insights into SXTC stock on TipRanks’ Stock Analysis page.